Canadian VIGOUR Centre
11
0
0
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 55/100
18.2%
2 terminated/withdrawn out of 11 trials
75.0%
-11.5% vs industry average
36%
4 trials in Phase 3/4
33%
2 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
Heart Failure Efficacy and Research Trial (HEART) Platform
Role: collaborator
Ketone Ester for Treatment Of Acute Heart Failure
Role: collaborator
SONOthrombolysis in Patients With an ST-segment Elevation Myocardial Infarction With fibrinoLYSIS (SONOSTEMI-LYSIS) Trial
Role: collaborator
The PRESSURE CABG Cardiac Surgery Trial
Role: collaborator
MOIST Study: Multi-Organ Imaging With Serial Testing in COVID-19 Infected Patients
Role: collaborator
Beta Blocker De-prescription Following Coronary Artery Bypass Graft Surgery (BEEFBURGER Trial).
Role: collaborator
A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
Role: collaborator
Patient-reported Outcomes in Vericiguat-treated Patients With HFpEF
Role: collaborator
Remote Ischemic Conditioning in STEMI to Decrease Infarct Size
Role: collaborator
Providing Rapid Out of Hospital Acute Cardiovascular Treatment (PROACT)
Role: collaborator
A Study To Determine the Efficacy and Safety of REG1 Compared to Bivalirudin in Patients Undergoing PCI
Role: collaborator
All 11 trials loaded